Clostridium difficile With Diagenode Acquisition, Hologic Expects to Expand Panther Fusion Testing Menu Premium Diagenode already sells more than 30 real-time PCR tests that are CE-marked for the detection of bacteria, parasites, and viruses for multiple infectious diseases. C. Difficile Epigenomic Analysis Uncovers Highly Conserved Methyltransferase A group led by Mount Sinai researchers said this methyltransferase, which is involved in sporulation, could be targeted to fight infections. ChromaCode Debuts Instrument-Agnostic Multiplex Panel for Multi-Drug Resistant Infection Screening Premium The firm's tick-borne pathogens panel was also recently the subject of a clinical study, showing high accuracy in detecting numerous infectious agents. Scope Fluidics Subsidiary Developing 15-Minute PCR System for POC Infectious Disease MDx Premium Based in Warsaw, Poland, the technology was inspired by "ultra-fast" PCR methods from the Wittwer group and Scope plans to launch tests for MRSA and C. diff. Clostridium Difficile Speciation Occurring in Healthcare Settings, Genomic Study Suggests An analysis of more than 900 C. difficile isolates uncovered four phylogenetic lineages, including three lineages in a clade showing recent positive selection on infection-related genes. Jul 31, 2019 Meridian Bioscience Dx Revenue Woes Likely to Continue Through 2020 Despite Promising Integration of GenePOC Premium May 14, 2019 Mobidiag Secures €25M Loan to Build Test Menu May 2, 2019 Meridian Biosciences Expects MDx Business Rejuvenation With GenePOC Acquisition Premium Nov 28, 2018 Signature Science Gets CDC Contract to Evaluate Molecular Microbial Detection Methods Nov 28, 2018 Johns Hopkins Researchers Working on Tool to Combat C. Difficile Overtesting Premium Nov 15, 2018 Hospitals Build Case for Pathogen Sequencing to Track Resistance, Monitor Outbreaks Premium Nov 8, 2018 Meridian Bioscience Q4 Revenues Grow 7 Percent Oct 23, 2018 GenePOC's Investment in Small Molecular Diagnostic Panels Validated by Medicare Decision, Company Says Premium Oct 23, 2018 GenePOC C. Diff MDx Approved in Canada Jul 31, 2018 Meridian Bioscience Q3 Revenues Grow 3 Percent Apr 9, 2018 Vanderbilt Applies DNA Biorepository, PheWAS to Speed Drug Repurposing Research Premium Feb 14, 2018 Donor, Recipient Strain Analyses Offer Fecal Transplant Engraftment Clues Jan 12, 2018 JPM Healthcare Day Four: Natera and Luminex Nov 28, 2017 GenePOC C. Diff Test Receives FDA Approval Nov 27, 2017 Interlux to Distribute Mobidiag Products in Estonia Oct 9, 2017 FDA Clears Roche C. Difficile Assay for Liat Platform Aug 7, 2017 Luminex Q2 Revenues Up 19 Percent; Firm to Delay Verigene 2 FDA Submission Jul 27, 2017 Meridian Bio Q3 Revenues Inch Down 1 Percent Jul 24, 2017 Luminex Receives FDA Clearance for C. Diff Assay May 30, 2017 MobiDiag Extends Distribution Agreement With PerkinElmer Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.